{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:28:36Z","timestamp":1786120116505,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/inf.0b013e31822d28df","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T12:14:10Z","timestamp":1312460050000},"page":"e225-e234","source":"Crossref","is-referenced-by-count":29,"title":["Immunogenicity and Safety of Human Papillomavirus-16\/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and\/or Meningococcal Conjugate Vaccine to Healthy Girls 11 to 18 Years of Age"],"prefix":"10.1097","volume":"30","author":[{"given":"Cosette M.","family":"Wheeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Pichichero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Blatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Catteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Dobbelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Schuind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-38-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":". Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R2-38-20210202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":". The causal relation between human papillomavirus and cervical cancer.","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"R3-38-20210202","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":". Epidemiologic classification of human papillomavirus types associated with cervical cancer.","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-38-20210202","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":". Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"R5-38-20210202","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":". Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication.","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"key":"R6-38-20210202","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1086\/426867","article-title":". A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.","volume":"191","author":"Brown","year":"2005","journal-title":"J Infect Dis"},{"key":"R7-38-20210202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1155\/2007\/136906","article-title":"HPV infections in adolescents.","volume":"23","author":"Moscicki","year":"2007","journal-title":"Dis Markers"},{"key":"R8-38-20210202","first-page":"1","article-title":". Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R9-38-20210202","first-page":"1","article-title":"Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"R13-38-20210202","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/JCM.20.4.772-774.1984","article-title":". Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum.","volume":"20","author":"Camargo","year":"1984","journal-title":"J Clin Microbiol"},{"key":"R14-38-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-1157(83)80038-9","article-title":"A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.","volume":"11","author":"Melville-Smith","year":"1983","journal-title":"J Biol Stand"},{"key":"R15-38-20210202","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1099\/00222615-15-1-85","article-title":". Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay.","volume":"15","author":"Granstrom","year":"1982","journal-title":"J Med Microbiol"},{"key":"R16-38-20210202","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/infdis\/146.6.741","article-title":". Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen.","volume":"146","author":"Granstrom","year":"1982","journal-title":"J Infect Dis"},{"key":"R17-38-20210202","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/hv.4.6.6912","article-title":". Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-1618 cervical cancer vaccine.","volume":"4","author":"Dessy","year":"2008","journal-title":"Hum Vaccin"},{"key":"R20-38-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":". Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R21-38-20210202","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R22-38-20210202","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection-serum bactericidal antibody activity.","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"R23-38-20210202","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.vaccine.2010.11.057","article-title":". Immunogenicity and reactogenicity of co-administered tetanus-diphtheria-acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration.","volume":"29","author":"Weston","year":"2011","journal-title":"Vaccine"},{"key":"R24-38-20210202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jadohealth.2009.11.205","article-title":". Immunogenicity and safety of human papillomavirus-1618 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women.","volume":"46","author":"Garcia-Sicilia","year":"2010","journal-title":"J Adolesc Health"},{"key":"R27-38-20210202","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1542\/peds.2005-1759","article-title":". Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.","volume":"117","author":"Pichichero","year":"2006","journal-title":"Pediatrics"},{"key":"R28-38-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":". Efficacy of human papillomavirus (HPV)-1618 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"R29-38-20210202","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jadohealth.2007.02.015","article-title":". Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.","volume":"40","author":"Pedersen","year":"2007","journal-title":"J Adolesc Health"},{"key":"R30-38-20210202","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":". AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol"},{"key":"R31-38-20210202","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/INF.0b013e3181c177fb","article-title":". An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6111618) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.","volume":"29","author":"Vesikari","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R32-38-20210202","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.2009-2336","article-title":". Safety, tolerability, and immunogenicity of Gardasil given concomitantly with Menactra and Adacel.","volume":"125","author":"Reisinger","year":"2010","journal-title":"Pediatrics"},{"key":"R33-38-20210202","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2010.02.045","article-title":". Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.","volume":"28","author":"Arguedas","year":"2010","journal-title":"Vaccine"},{"key":"R34-38-20210202","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4161\/hv.5.5.7211","article-title":". Safety of human papillomavirus (HPV)-1618 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials.","volume":"5","author":"Descamps","year":"2009","journal-title":"Hum Vaccin"},{"key":"R35-38-20210202","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1016\/j.vaccine.2008.09.049","article-title":". Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines.","volume":"26","author":"Verstraeten","year":"2008","journal-title":"Vaccine"},{"key":"R36-38-20210202","doi-asserted-by":"crossref","first-page":"c712","DOI":"10.1136\/bmj.c712","article-title":". Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials.","volume":"340","author":"Wacholder","year":"2010","journal-title":"BMJ"},{"key":"R37-38-20210202","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00063030-200620060-00008","article-title":"Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization.","volume":"20","author":"Frampton","year":"2006","journal-title":"BioDrugs"},{"key":"R38-38-20210202","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":". Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R39-38-20210202","first-page":"1","article-title":". General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e31822d28df","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:13:30Z","timestamp":1786047210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201112000-00038"}},"subtitle":["Results From a Randomized Open Trial"],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31822d28df","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}